Pediapharm (CVE:PDP) Trading Up 1.7% – What’s Next?
by Danessa Lincoln · The Markets DailyPediapharm Inc. (CVE:PDP – Get Free Report)’s stock price shot up 1.7% on Wednesday . The company traded as high as C$0.31 and last traded at C$0.30. 26,000 shares were traded during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The stock’s 50-day moving average price is C$0.30 and its 200-day moving average price is C$0.30. The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87. The company has a market capitalization of C$66.36 million and a P/E ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.